Study Group: Ranexa Prescribers: Heart Failure Specialists (US)(?)
Council Members in this Study Group: 20
Request a survey with this Study Group
Leading Experts in this Study Group
Clinical Director
New York University Medical Center
Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...
Hossein Ardehali, MD, PhDAssistant Professor
Feinberg School of Medicine, Northwestern University
Hossein Ardehali, MD, PhD, is an Assistant Professor of Medicine at Feinberg Cardiovascular Institute in Illinois. His specialties include lipid metabolism, preventive cardiology, electrophysiology and heart failure. Dr. Ardehali's basic science research interest is in the areas of reperfusion injury...
Samuel Butman, MDInterventional Cardiologist
Verde Valley Heart LLC
Samuel Butman, MD, is an Interventional Cardiologist at Verde Valley Medical Center. Dr. Butman is also a Clinical Associate Professor of Medicine at University Medical Center in Tucson, Arizona. He has also served as the Director of Cardiology Interventional Fellows Program and Director of Cardiac...
Bernard Chaitman, MDProfessor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies, including Ranolazine, Nicorandil,...
Cardiologist/ Electrophysiologist
Cardiac Solutions
Jesse Sethi, MD, FACC, is a Cardiologist and Electrophysiologist at Cardiac Solutions, a private practice in Arizona. Dr. Sethi has expertise in electrophysiology procedures such as pacemakers, defibrillators (ICDs), biventricular ICDs, cardiac resynchronization therapy (CRT), atrial and ventricular...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
It is well known that the addition of thiazide diuretic to ACEI or ARB treatment adds about 10 mm Hg reduction on top of the 10 mm Hg reduction provided by the ACEI or ARB agent. It is expected that blocking renin in the renin angiotensin system with Tekturna would provide a similar result.
Questions about bleeding, proper dose and appropriate patient subsets will limit use
TRITON-TIMI 38 study of 13,608 patients with ACS compared prasugrel against clopidogrel, combined with aspirin. Prasugrel reduced the combined rate of CV death, MI or stroke (12.1% for clopidogrel vs. 9.9% for prasugrel). The benefit came at a cost of increased serious bleeding (1.4%, vs....
The reality that the actual details of the ENHANCE have not been circulated and that alternate explanations or caveats may be raised is probably unimportant. The bottom line carries the day and the bottom line is that the trial's title, ENHANCE, was not achieved by the addition of VYTORIN when...
The impact on Vytorin and zetia sales will be modest reduction after the release of ENHANCE data
Physicians have several possible conclusions that can be taken; These include: - the trial is flawed - the selection of patients with much less CIMT than previous trials such as ASAP and ARBITER flaws the study - the failure to meet the trial endpoint is only a surrogate and clinical trial data...
This is great news for Canada. This is the first new drug approved for the treatment of acute heart failure since 1989, when milrinone was approved. Nesiritide was approved in the United States in 2001. Since then, it has proven to be of great benefit in patients with acute heart failure,...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Partner
- Physician - Department Chair
- Physician - Division Head
- Researcher